GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (FRA:RVKA) » Definitions » Cash Ratio

Cambridge Nutritional Sciences (FRA:RVKA) Cash Ratio : 2.33 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cambridge Nutritional Sciences Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Cambridge Nutritional Sciences's Cash Ratio for the quarter that ended in Sep. 2023 was 2.33.

Cambridge Nutritional Sciences has a Cash Ratio of 2.33. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Cambridge Nutritional Sciences's Cash Ratio or its related term are showing as below:

FRA:RVKA' s Cash Ratio Range Over the Past 10 Years
Min: 0.04   Med: 1.01   Max: 4.51
Current: 2.33

During the past 13 years, Cambridge Nutritional Sciences's highest Cash Ratio was 4.51. The lowest was 0.04. And the median was 1.01.

FRA:RVKA's Cash Ratio is ranked better than
67.8% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.2 vs FRA:RVKA: 2.33

Cambridge Nutritional Sciences Cash Ratio Historical Data

The historical data trend for Cambridge Nutritional Sciences's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Cash Ratio Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.91 0.47 2.64

Cambridge Nutritional Sciences Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.47 0.97 2.64 2.33

Competitive Comparison of Cambridge Nutritional Sciences's Cash Ratio

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Cash Ratio falls into.



Cambridge Nutritional Sciences Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Cambridge Nutritional Sciences's Cash Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash Ratio (A: Mar. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=5.798/2.193
=2.64

Cambridge Nutritional Sciences's Cash Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash Ratio (Q: Sep. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=5.098/2.186
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cambridge Nutritional Sciences  (FRA:RVKA) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Cambridge Nutritional Sciences Cash Ratio Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences (FRA:RVKA) Business Description

Traded in Other Exchanges
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The company develops, manufacture and market pioneering diagnostic products associated with food sensitivity and gut health. These products enable healthcare practitioners to make informed decisions that can transform their patients' long-term health.

Cambridge Nutritional Sciences (FRA:RVKA) Headlines

No Headlines